Showing results (171-180 of 4,346) with videos related to

Sort By:
Pageof 435
Cancer|July 1, 1977
A phase II study of triazinate (NSC 139105) in advanced colorectal carcinomaR H McCreary, C G Moertel, A J Schutt, et al.
Annals of Internal Medicine|December 1, 1979
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placeboS Frytak, C G Moertel, J R O'Fallon, et al.
Annals of Neurology|March 1, 1992
Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisoleC C Hook, D W Kimmel, L K Kvols, et al.
Epidemiology (Cambridge, Mass.)|July 1, 1995
Uranium dust exposure and lung cancer risk in four uranium processing operationsE A Dupree, J P Watkins, J N Ingle, et al.
Cancer|June 1, 1983
Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancerE T Creagan, J R O'Fallon, J E Woods, et al.
Cancer Research|November 21, 2000
Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblastsG G Reinholz, B Getz, L Pederson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancerE T Creagan, S J Green, D L Ahmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drugD L Ahmann, D J Schaid, H F Bisel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancerJ K Camoriano, C L Loprinzi, J N Ingle, et al.
American Journal of Clinical Oncology|October 1, 1988
Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapyH J Long, D J Schaid, A J Schutt, et al.
Pageof 435